21911-Tailoring LDL-C-Lowering Therapy to Patient Cardiovascular Risk

In this program, a panel of experts will discuss the latest guidelines for managing LDL-C in patients with diabetes, interpret data with nonstatin, LDL-C-lowering therapies, describe improving access to PCSK9 inhibitors and tips for achieving earlier access,

Login to your Account